Tak­ing on lousy side ef­fects of ex­ist­ing meds, NEA-backed Xoc tack­les Parkin­son’s/mi­graines with $30M Se­ries A

New En­ter­prise As­so­ciates is back­ing a start­up near San Jose that’s us­ing old clin­i­cal da­ta — paired with new tech — to come up with nov­el drugs …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA